Towards a serotonin-dependent leptin roadmap in the brain

Trends in Endocrinology and Metabolism

Volumn 22, Issue 9, 2011, Pages 382-387

  Oury, Franck ^a   Karsenty, Gerard ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LEPTIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

APPETITE DISORDER; ENERGY EXPENDITURE; ENERGY METABOLISM; FOOD INTAKE; HYPOTHALAMUS; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BRAIN; ENERGY METABOLISM; HUMANS; LEPTIN; MICE; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 80052388240     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2011.04.006     Document Type: Review

References (52)

1. Ducy P., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 100:197-207.
2. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
3. Zhang Y., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
4. Tartaglia L.A., et al. Identification and expression cloning of a leptin receptor OB-R. Cell 1995, 83:1263-1271.
5. Takeda S., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002, 111:305-317.
6. Elefteriou F., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
7. Boyden L.M., et al. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 2002, 346:1513-1521.
8. Huising M.O., et al. Increased leptin expression in common Carp (Cyprinus carpio) after food intake but not after fasting or feeding to satiation. Endocrinology 2006, 147:5786-5797.
9. Karsenty G., Oury F. The central regulation of bone mass, the first link between bone remodeling and energy metabolism. J. Clin. Endocrinol. Metab. 2010, 95:4795-4801.
10. Clement K., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998, 392:398-401.
11. Lee K., et al. Identification of a developmentally regulated protein tyrosine phosphatase in embryonic stem cells that is a marker of pluripotential epiblast and early mesoderm. Mech. Dev. 1996, 59:153-164.
12. Strobel A., et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 1998, 18:213-215.
13. Montague C.T., et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 387:903-908.
14. Chen H., et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84:491-495.
15. Bjornholm M., et al. Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. J. Clin. Invest. 2007, 117:1354-1360.
16. Shi Y., et al. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20529-20533.
17. Fei H., et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:7001-7005.
18. Ahima R.S., et al. Leptin regulation of neuroendocrine systems. Front. Neuroendocrinol. 2000, 21:263-307.
19. Hetherington A.W., Ranson S.W. Hypothalamic lesions and adipocity in the rat. Anat. Rec. 1940, 78:149.
20. Hetherington A.W., Ranson S.W. The relation of various hypothalamic lesions to adiposity in the rat. J. Comp. Neurol. 1942, 76:475-499.
21. Brobeck J.R. Mechanisms of the development of obesity in animals with hypothalamic lesions. Physiol. Rev. 1946, 26:541-559.
22. Anand B.K., Brobeck J.R. Localization of a feeding center in the hypothalamus of the rat. Proc. Soc. Exp. Biol. Med. 1951, 77:323-324.
23. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969, 164:719-721.
24. Halaas J.L., et al. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8878-8883.
25. Balthasar N., et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 2004, 42:983-991.
26. Yadav V.K., et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009, 138:976-989.
27. Haney E.M., et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch. Intern. Med. 2007, 167:1246-1251.
28. Kaye W., et al. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol. Psychiatry 1998, 44:825-838.
29. Laekeman G., et al. Osteoporosis after combined use of a neuroleptic and antidepressants. Pharm. World Sci. 2008, 30:613-616.
30. Richards J.B., et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch. Intern. Med. 2007, 167:188-194.
31. Ziere G., et al. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J. Clin. Psychopharmacol. 2008, 28:411-417.
32. Heath M.J., Hen R. Serotonin receptors. Genetic insights into serotonin function. Curr. Biol. 1995, 5:997-999.
33. Walther D.J., et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003, 299:76.
34. Mann J.J., et al. Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology. Biol. Psychiatry 1992, 32:243-257.
35. Oury F., et al. CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons. Genes Dev. 2010, 24:2330-2342.
36. Yadav V.K., et al. Leptin-dependent serotonin control of appetite: temporal specificity, transcriptional regulation, and therapeutic implications. J. Exp. Med. 2011, 208:41-52.
37. Dourish C.T., et al. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacol. (Berl.) 1985, 86:197-204.
38. Gilbert F., et al. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats. Psychoneuroendocrinology 1988, 13:471-478.
39. Neill J.C., Cooper S.J. MDL 72832, a selective 5-HT1A receptor ligand, stereospecifically increases food intake. Eur. J. Pharmacol. 1988, 151:329-332.
40. Moreau J.L., et al. Behavioral profile of the 5HT1A receptor antagonist (S)-UH-301 in rodents and monkeys. Brain Res. Bull. 1992, 29:901-904.
41. Nonogaki K., et al. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat. Med. 1998, 4:1152-1156.
42. Srinivasan S., et al. Serotonin regulates C. elegans fat and feeding through independent molecular mechanisms. Cell Metab. 2008, 7:533-544.
43. Halford J.C., Blundell J.E. Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence. Pharmacol. Biochem. Behav. 1996, 54:745-751.
44. Lee M.D., et al. Infusion of the serotonin1B (5-HT1B) agonist CP-93,129 into the parabrachial nucleus potently and selectively reduces food intake in rats. Psychopharmacol. (Berl.) 1998, 136:304-307.
45. Kennett G.A., Curzon G. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacol. (Berl.) 1988, 96:93-100.
46. Kitchener S.J., Dourish C.T. An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats. Psychopharmacol. (Berl) 1994, 113:369-377.
47. Bonhaus D.W., et al. RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 1997, 36:621-629.
48. Fernandez-Galaz M.C. Leptin accumulation in hypothalamic and dorsal raphe neurons is inversely correlated with brain serotonin content. Brain Res. 2010, 1329:194-202.
49. Bates S.H., Myers M.G. The role of leptin-STAT3 signaling in neuroendocrine function: an integrative perspective. J. Mol. Med. 2004, 82:12-20.
50. Stahl N., et al. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995, 267:1349-1353.
51. White D.W., et al. Leptin receptor (OB-R) signaling Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J. Biol. Chem. 1997, 272:4065-4071.
52. Banks A.S., et al. Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 2000, 275:14563-14572.